<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-02-01" modified="2017-11-22" version="187">
<accession>P47712</accession>
<accession>B1AKG4</accession>
<accession>Q29R80</accession>
<name>PA24A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Cytosolic phospholipase A2</fullName>
<shortName>cPLA2</shortName>
</recommendedName>
<alternativeName>
<fullName>Phospholipase A2 group IVA</fullName>
</alternativeName>
<domain>
<recommendedName>
<fullName>Phospholipase A2</fullName>
<ecNumber>3.1.1.4</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Phosphatidylcholine 2-acylhydrolase</fullName>
</alternativeName>
</domain>
<domain>
<recommendedName>
<fullName>Lysophospholipase</fullName>
<ecNumber>3.1.1.5</ecNumber>
</recommendedName>
</domain>
</protein>
<gene>
<name type="primary">PLA2G4A</name>
<name type="synonym">CPLA2</name>
<name type="synonym">PLA2G4</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Cell" volume="65" first="1043" last="1051">
<title>A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP.</title>
<authorList>
<person name="Clark J.D."/>
<person name="Lin L.-L."/>
<person name="Kriz R.W."/>
<person name="Ramesha C.S."/>
<person name="Sultzman L.A."/>
<person name="Lin A.Y."/>
<person name="Milona N."/>
<person name="Knopf J.L."/>
</authorList>
<dbReference type="PubMed" id="1904318"/>
<dbReference type="DOI" id="10.1016/0092-8674(91)90556-E"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>VARIANT LYS-651</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="14850" last="14853">
<title>Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2.</title>
<authorList>
<person name="Sharp J."/>
<person name="White D."/>
<person name="Chiou G."/>
<person name="Goodson T."/>
<person name="Gamboa G."/>
<person name="McClure D."/>
<person name="Burgett S."/>
<person name="Hoskins J."/>
<person name="Skatrud P."/>
<person name="Sportsman J."/>
<person name="Becker G."/>
<person name="Kang L."/>
<person name="Roberts E."/>
<person name="Kramer R."/>
</authorList>
<dbReference type="PubMed" id="1869522"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT LYS-651</scope>
</reference>
<reference key="3">
<citation type="submission" date="2004-02" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS ILE-224 AND LYS-651</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT LYS-651</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1993" name="Cell" volume="72" first="269" last="278">
<title>cPLA2 is phosphorylated and activated by MAP kinase.</title>
<authorList>
<person name="Lin L.-L."/>
<person name="Wartmann M."/>
<person name="Lin A.Y."/>
<person name="Knopf J.L."/>
<person name="Seth A."/>
<person name="Davis R.J."/>
</authorList>
<dbReference type="PubMed" id="8381049"/>
<dbReference type="DOI" id="10.1016/0092-8674(93)90666-E"/>
</citation>
<scope>MUTAGENESIS OF SER-505</scope>
<scope>PHOSPHORYLATION AT SER-505</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="23250" last="23254">
<title>Serine 228 is essential for catalytic activities of 85-kDa cytosolic phospholipase A2.</title>
<authorList>
<person name="Sharp J.D."/>
<person name="Pickard R.T."/>
<person name="Chiou X.G."/>
<person name="Manetta J.V."/>
<person name="Kovacevic S."/>
<person name="Miller J.R."/>
<person name="Varshavsky A.D."/>
<person name="Roberts E.F."/>
<person name="Strifler B.A."/>
<person name="Brems D.N."/>
<person name="Kramer R.M."/>
</authorList>
<dbReference type="PubMed" id="8083230"/>
</citation>
<scope>ACTIVE SITE</scope>
<scope>MUTAGENESIS OF CYS-139; CYS-141; CYS-151; SER-195; SER-215; CYS-220; SER-228; CYS-324; CYS-331; SER-577; CYS-620; CYS-634 AND CYS-726</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1996" name="Biochemistry" volume="35" first="3712" last="3721">
<title>Functional identification of the active-site nucleophile of the human 85-kDa cytosolic phospholipase A2.</title>
<authorList>
<person name="Huang Z."/>
<person name="Payette P."/>
<person name="Abdullah K."/>
<person name="Cromlish W.A."/>
<person name="Kennedy B.P."/>
</authorList>
<dbReference type="PubMed" id="8619991"/>
<dbReference type="DOI" id="10.1021/bi952541k"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ACTIVE SITE</scope>
<scope>MUTAGENESIS OF SER-228</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="19225" last="19231">
<title>Identification of essential residues for the catalytic function of 85-kDa cytosolic phospholipase A2. Probing the role of histidine, aspartic acid, cysteine, and arginine.</title>
<authorList>
<person name="Pickard R.T."/>
<person name="Chiou X.G."/>
<person name="Strifler B.A."/>
<person name="DeFelippis M.R."/>
<person name="Hyslop P.A."/>
<person name="Tebbe A.L."/>
<person name="Yee Y.K."/>
<person name="Reynolds L.J."/>
<person name="Dennis E.A."/>
<person name="Kramer R.M."/>
<person name="Sharp J.D."/>
</authorList>
<dbReference type="PubMed" id="8702602"/>
<dbReference type="DOI" id="10.1074/jbc.271.32.19225"/>
</citation>
<scope>ACTIVE SITE</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF ARG-200; SER-228 AND ASP-549</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="4449" last="4458">
<title>Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells.</title>
<authorList>
<person name="Boersch-Haubold A.G."/>
<person name="Bartoli F."/>
<person name="Asselin J."/>
<person name="Dudler T."/>
<person name="Kramer R.M."/>
<person name="Apitz-Castro R."/>
<person name="Watson S.P."/>
<person name="Gelb M.H."/>
</authorList>
<dbReference type="PubMed" id="9468497"/>
<dbReference type="DOI" id="10.1074/jbc.273.8.4449"/>
</citation>
<scope>PHOSPHORYLATION AT SER-505 AND SER-727</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="4470" last="4481">
<title>PLIP, a novel splice variant of Tip60, interacts with group IV cytosolic phospholipase A(2), induces apoptosis, and potentiates prostaglandin production.</title>
<authorList>
<person name="Sheridan A.M."/>
<person name="Force T."/>
<person name="Yoon H.J."/>
<person name="O'Leary E."/>
<person name="Choukroun G."/>
<person name="Taheri M.R."/>
<person name="Bonventre J.V."/>
</authorList>
<dbReference type="PubMed" id="11416127"/>
<dbReference type="DOI" id="10.1128/MCB.21.14.4470-4481.2001"/>
</citation>
<scope>INTERACTION WITH KAT5</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-729</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="J. Clin. Invest." volume="118" first="2121" last="2131">
<title>Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction.</title>
<authorList>
<person name="Adler D.H."/>
<person name="Cogan J.D."/>
<person name="Phillips J.A."/>
<person name="Schnetz-Boutaud N."/>
<person name="Milne G.L."/>
<person name="Iverson T."/>
<person name="Stein J.A."/>
<person name="Brenner D.A."/>
<person name="Morrow J.D."/>
<person name="Boutaud O."/>
<person name="Oates J.A."/>
</authorList>
<dbReference type="PubMed" id="18451993"/>
<dbReference type="DOI" id="10.1172/JCI30473"/>
</citation>
<scope>INVOLVEMENT IN PHOSPHOLIPASE A2 DEFICIENCY</scope>
<scope>VARIANTS PRO-111; HIS-485 AND LYS-651</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="526" last="534">
<title>Phosphoproteome of resting human platelets.</title>
<authorList>
<person name="Zahedi R.P."/>
<person name="Lewandrowski U."/>
<person name="Wiesner J."/>
<person name="Wortelkamp S."/>
<person name="Moebius J."/>
<person name="Schuetz C."/>
<person name="Walter U."/>
<person name="Gambaryan S."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="18088087"/>
<dbReference type="DOI" id="10.1021/pr0704130"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-268; SER-437; SER-727 AND SER-729</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-268; SER-437 AND SER-729</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-437</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; THR-268; SER-435; SER-437; SER-727 AND SER-729</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-541 AND LYS-606</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="1596" last="1604">
<title>Crystal structure of a calcium-phospholipid binding domain from cytosolic phospholipase A2.</title>
<authorList>
<person name="Perisic O."/>
<person name="Fong S."/>
<person name="Lynch D.E."/>
<person name="Bycroft M."/>
<person name="Williams R.L."/>
</authorList>
<dbReference type="PubMed" id="9430701"/>
<dbReference type="DOI" id="10.1074/jbc.273.3.1596"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 16-141 IN COMPLEX WITH CALCIUM IONS</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1998" name="J. Mol. Biol." volume="280" first="485" last="500">
<title>Solution structure and membrane interactions of the C2 domain of cytosolic phospholipase A2.</title>
<authorList>
<person name="Xu G.-Y."/>
<person name="McDonagh T."/>
<person name="Yu H.-A."/>
<person name="Nalefski E.A."/>
<person name="Clark J.D."/>
<person name="Cumming D.A."/>
</authorList>
<dbReference type="PubMed" id="9665851"/>
<dbReference type="DOI" id="10.1006/jmbi.1998.1874"/>
</citation>
<scope>STRUCTURE BY NMR OF 1-138 IN COMPLEX WITH CALCIUM IONS</scope>
<scope>DOMAIN</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1999" name="Cell" volume="97" first="349" last="360">
<title>Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism.</title>
<authorList>
<person name="Dessen A."/>
<person name="Tang J."/>
<person name="Schmidt H."/>
<person name="Stahl M."/>
<person name="Clark J.D."/>
<person name="Seehra J."/>
<person name="Somers W.S."/>
</authorList>
<dbReference type="PubMed" id="10319815"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80744-8"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH CALCIUM IONS</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] GLN-442</scope>
</reference>
<comment type="function">
<text>Selectively hydrolyzes arachidonyl phospholipids in the sn-2 position releasing arachidonic acid. Together with its lysophospholipid activity, it is implicated in the initiation of the inflammatory response.</text>
</comment>
<comment type="catalytic activity">
<text>Phosphatidylcholine + H(2)O = 1-acylglycerophosphocholine + a carboxylate.</text>
</comment>
<comment type="catalytic activity">
<text>2-lysophosphatidylcholine + H(2)O = glycerophosphocholine + a carboxylate.</text>
</comment>
<comment type="enzyme regulation">
<text>Stimulated by agonists such as ATP, EGF, thrombin and bradykinin as well as by cytosolic Ca(2+).</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<Vmax evidence="20">2.7 umol/min/mg enzyme for the phospholipase A2 reaction</Vmax>
<Vmax evidence="20">4.6 umol/min/mg enzyme for the lysophosphatase reaction</Vmax>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="13 14 24 26">Interacts with KAT5.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasmic vesicle</location>
</subcellularLocation>
<text>Translocates to membrane vesicles in a calcium-dependent fashion.</text>
</comment>
<comment type="tissue specificity">
<text>Expressed in various tissues such as macrophages, platelets, neutrophils, fibroblasts and lung endothelium.</text>
</comment>
<comment type="domain">
<text evidence="24 26">The N-terminal C2 domain associates with lipid membranes upon calcium binding. It modulates enzyme activity by presenting the active site to its substrate in response to elevations of cytosolic Ca(2+).</text>
</comment>
<comment type="PTM">
<text evidence="21 25">Activated by phosphorylation at both Ser-505 and Ser-727.</text>
</comment>
<comment type="disease">
<text evidence="17">PLA2G4A mutations resulting in phospholipase A2 deficiency have been found in a patient affected by recurrent episodes of multiple complicated ulcers of the small intestine, not due to cyclooxygenase inhibitors use. Disease features also include platelet dysfunction, and globally decreased eicosanoid synthesis (PubMed:18451993).</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/pla2g4a/"/>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PLA2G4AID41733ch1q31.html"/>
</comment>
<dbReference type="EC" id="3.1.1.4"/>
<dbReference type="EC" id="3.1.1.5"/>
<dbReference type="EMBL" id="M72393">
<property type="protein sequence ID" value="AAB00789.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M68874">
<property type="protein sequence ID" value="AAA60105.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY552098">
<property type="protein sequence ID" value="AAS45712.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL022147">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL049797">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC114340">
<property type="protein sequence ID" value="AAI14341.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1372.1"/>
<dbReference type="PIR" id="A39329">
<property type="entry name" value="A39329"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001298122.1">
<property type="nucleotide sequence ID" value="NM_001311193.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_077734.1">
<property type="nucleotide sequence ID" value="NM_024420.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011507944.1">
<property type="nucleotide sequence ID" value="XM_011509642.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.497200"/>
<dbReference type="PDB" id="1BCI">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-138"/>
</dbReference>
<dbReference type="PDB" id="1CJY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=1-749"/>
</dbReference>
<dbReference type="PDB" id="1RLW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=17-141"/>
</dbReference>
<dbReference type="PDBsum" id="1BCI"/>
<dbReference type="PDBsum" id="1CJY"/>
<dbReference type="PDBsum" id="1RLW"/>
<dbReference type="ProteinModelPortal" id="P47712"/>
<dbReference type="SMR" id="P47712"/>
<dbReference type="BioGrid" id="111338">
<property type="interactions" value="33"/>
</dbReference>
<dbReference type="DIP" id="DIP-40991N"/>
<dbReference type="IntAct" id="P47712">
<property type="interactions" value="9"/>
</dbReference>
<dbReference type="MINT" id="MINT-118843"/>
<dbReference type="STRING" id="9606.ENSP00000356436"/>
<dbReference type="BindingDB" id="P47712"/>
<dbReference type="ChEMBL" id="CHEMBL3816"/>
<dbReference type="DrugBank" id="DB00041">
<property type="generic name" value="Aldesleukin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00411">
<property type="generic name" value="Carbachol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00578">
<property type="generic name" value="Carbenicillin"/>
</dbReference>
<dbReference type="DrugBank" id="DB05029">
<property type="generic name" value="Duramycin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00445">
<property type="generic name" value="Epirubicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB04827">
<property type="generic name" value="Ethyl carbamate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00591">
<property type="generic name" value="Fluocinolone Acetonide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00588">
<property type="generic name" value="Fluticasone Propionate"/>
</dbReference>
<dbReference type="DrugBank" id="DB04552">
<property type="generic name" value="Niflumic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01083">
<property type="generic name" value="Orlistat"/>
</dbReference>
<dbReference type="DrugBank" id="DB01103">
<property type="generic name" value="Quinacrine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00086">
<property type="generic name" value="Streptokinase"/>
</dbReference>
<dbReference type="DrugBank" id="DB04786">
<property type="generic name" value="Suramin"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1424"/>
<dbReference type="SwissLipids" id="SLP:000000565"/>
<dbReference type="iPTMnet" id="P47712"/>
<dbReference type="PhosphoSitePlus" id="P47712"/>
<dbReference type="BioMuta" id="PLA2G4A"/>
<dbReference type="DMDM" id="317373312"/>
<dbReference type="EPD" id="P47712"/>
<dbReference type="MaxQB" id="P47712"/>
<dbReference type="PaxDb" id="P47712"/>
<dbReference type="PeptideAtlas" id="P47712"/>
<dbReference type="PRIDE" id="P47712"/>
<dbReference type="Ensembl" id="ENST00000367466">
<property type="protein sequence ID" value="ENSP00000356436"/>
<property type="gene ID" value="ENSG00000116711"/>
</dbReference>
<dbReference type="GeneID" id="5321"/>
<dbReference type="KEGG" id="hsa:5321"/>
<dbReference type="UCSC" id="uc001gsc.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5321"/>
<dbReference type="DisGeNET" id="5321"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000116711.9"/>
<dbReference type="GeneCards" id="PLA2G4A"/>
<dbReference type="HGNC" id="HGNC:9035">
<property type="gene designation" value="PLA2G4A"/>
</dbReference>
<dbReference type="HPA" id="CAB010050"/>
<dbReference type="HPA" id="HPA050062"/>
<dbReference type="HPA" id="HPA054206"/>
<dbReference type="MalaCards" id="PLA2G4A"/>
<dbReference type="MIM" id="600522">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P47712"/>
<dbReference type="OpenTargets" id="ENSG00000116711"/>
<dbReference type="PharmGKB" id="PA271"/>
<dbReference type="eggNOG" id="KOG1012">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="KOG1325">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XR72">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00550000074489"/>
<dbReference type="HOGENOM" id="HOG000115420"/>
<dbReference type="HOVERGEN" id="HBG053479"/>
<dbReference type="InParanoid" id="P47712"/>
<dbReference type="KO" id="K16342"/>
<dbReference type="OMA" id="RFSMALC"/>
<dbReference type="OrthoDB" id="EOG091G0276"/>
<dbReference type="PhylomeDB" id="P47712"/>
<dbReference type="TreeFam" id="TF325228"/>
<dbReference type="BioCyc" id="MetaCyc:HS04039-MONOMER"/>
<dbReference type="BRENDA" id="3.1.1.4">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-111995">
<property type="pathway name" value="phospho-PLA2 pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1482788">
<property type="pathway name" value="Acyl chain remodelling of PC"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1482798">
<property type="pathway name" value="Acyl chain remodeling of CL"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1482801">
<property type="pathway name" value="Acyl chain remodelling of PS"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1482839">
<property type="pathway name" value="Acyl chain remodelling of PE"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1482922">
<property type="pathway name" value="Acyl chain remodelling of PI"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1482925">
<property type="pathway name" value="Acyl chain remodelling of PG"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1483115">
<property type="pathway name" value="Hydrolysis of LPC"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1483166">
<property type="pathway name" value="Synthesis of PA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2142753">
<property type="pathway name" value="Arachidonic acid metabolism"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-418592">
<property type="pathway name" value="ADP signalling through P2Y purinoceptor 1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-432142">
<property type="pathway name" value="Platelet sensitization by LDL"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811436">
<property type="pathway name" value="COPI-independent Golgi-to-ER retrograde traffic"/>
</dbReference>
<dbReference type="SIGNOR" id="P47712"/>
<dbReference type="EvolutionaryTrace" id="P47712"/>
<dbReference type="GeneWiki" id="PLA2G4A"/>
<dbReference type="GenomeRNAi" id="5321"/>
<dbReference type="PMAP-CutDB" id="P47712"/>
<dbReference type="PRO" id="PR:P47712"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000116711"/>
<dbReference type="CleanEx" id="HS_PLA2G4A"/>
<dbReference type="Genevisible" id="P47712">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0031410">
<property type="term" value="C:cytoplasmic vesicle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005811">
<property type="term" value="C:lipid droplet"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005743">
<property type="term" value="C:mitochondrial inner membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005509">
<property type="term" value="F:calcium ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0047498">
<property type="term" value="F:calcium-dependent phospholipase A2 activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005544">
<property type="term" value="F:calcium-dependent phospholipid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004622">
<property type="term" value="F:lysophospholipase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008970">
<property type="term" value="F:phosphatidylcholine 1-acylhydrolase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004623">
<property type="term" value="F:phospholipase A2 activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0102567">
<property type="term" value="F:phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine)"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0102568">
<property type="term" value="F:phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0019369">
<property type="term" value="P:arachidonic acid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050482">
<property type="term" value="P:arachidonic acid secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035965">
<property type="term" value="P:cardiolipin acyl-chain remodeling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0071236">
<property type="term" value="P:cellular response to antibiotic"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046456">
<property type="term" value="P:icosanoid biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006690">
<property type="term" value="P:icosanoid metabolic process"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006654">
<property type="term" value="P:phosphatidic acid biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0036151">
<property type="term" value="P:phosphatidylcholine acyl-chain remodeling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0036152">
<property type="term" value="P:phosphatidylethanolamine acyl-chain remodeling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0036148">
<property type="term" value="P:phosphatidylglycerol acyl-chain remodeling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0036149">
<property type="term" value="P:phosphatidylinositol acyl-chain remodeling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0036150">
<property type="term" value="P:phosphatidylserine acyl-chain remodeling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0009395">
<property type="term" value="P:phospholipid catabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0006644">
<property type="term" value="P:phospholipid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006663">
<property type="term" value="P:platelet activating factor biosynthetic process"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.150">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR016035">
<property type="entry name" value="Acyl_Trfase/lysoPLipase"/>
</dbReference>
<dbReference type="InterPro" id="IPR000008">
<property type="entry name" value="C2_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035892">
<property type="entry name" value="C2_domain_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR002642">
<property type="entry name" value="LysoPLipase_cat_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF00168">
<property type="entry name" value="C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01735">
<property type="entry name" value="PLA2_B"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00239">
<property type="entry name" value="C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00022">
<property type="entry name" value="PLAc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49562">
<property type="entry name" value="SSF49562"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52151">
<property type="entry name" value="SSF52151"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50004">
<property type="entry name" value="C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51210">
<property type="entry name" value="PLA2C"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0442">Lipid degradation</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Cytosolic phospholipase A2" id="PRO_0000187262">
<location>
<begin position="1"/>
<end position="749"/>
</location>
</feature>
<feature type="domain" description="C2" evidence="11">
<location>
<begin position="5"/>
<end position="106"/>
</location>
</feature>
<feature type="domain" description="PLA2c" evidence="12">
<location>
<begin position="140"/>
<end position="740"/>
</location>
</feature>
<feature type="region of interest" description="Phospholipid binding" evidence="28">
<location>
<begin position="1"/>
<end position="178"/>
</location>
</feature>
<feature type="active site" description="Nucleophile" evidence="13 20 22 23">
<location>
<position position="228"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="13 23">
<location>
<position position="549"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1">
<location>
<position position="40"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2">
<location>
<position position="40"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1; via carbonyl oxygen">
<location>
<position position="41"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1">
<location>
<position position="43"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2">
<location>
<position position="43"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1">
<location>
<position position="65"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2">
<location>
<position position="93"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2; via carbonyl oxygen">
<location>
<position position="94"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2">
<location>
<position position="95"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5 6 8">
<location>
<position position="268"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="434"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="435"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6 7 8">
<location>
<position position="437"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK" evidence="21 25">
<location>
<position position="505"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="515"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 8 25">
<location>
<position position="727"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5 6 8">
<location>
<position position="729"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="9">
<location>
<position position="541"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="9">
<location>
<position position="606"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28395828." id="VAR_029276">
<original>G</original>
<variation>R</variation>
<location>
<position position="103"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated mutation found in a compound heterozygote affected by phospholipase A2 deficiency also carrying H-485; dbSNP:rs121434634." id="VAR_070778" evidence="17">
<original>S</original>
<variation>P</variation>
<location>
<position position="111"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12720588." id="VAR_018760" evidence="27">
<original>V</original>
<variation>I</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_035826" evidence="16">
<original>H</original>
<variation>Q</variation>
<location>
<position position="442"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated mutation found in a compound heterozygote affected by phospholipase A2 deficiency also carrying P-111; dbSNP:rs121434635." id="VAR_070779" evidence="17">
<original>R</original>
<variation>H</variation>
<location>
<position position="485"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28395831." id="VAR_062128">
<original>I</original>
<variation>V</variation>
<location>
<position position="637"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2307198." id="VAR_018424" evidence="15 17 18 19 27">
<original>R</original>
<variation>K</variation>
<location>
<position position="651"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phospholipase activity; when associated with A-141 and A-151." evidence="20">
<original>C</original>
<variation>A</variation>
<location>
<position position="139"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phospholipase activity; when associated with A-139 and A-151." evidence="20">
<original>C</original>
<variation>A</variation>
<location>
<position position="141"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phospholipase activity; when associated with A-139 and A-141." evidence="20">
<original>C</original>
<variation>A</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="mutagenesis site" description="5-fold reduced phospholipase and lysophosphatase activities. 100-fold reduced phospholipase and lysophosphatase activities; when associated with A-577." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phospholipase activity." evidence="23">
<original>R</original>
<variation>A</variation>
<variation>H</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces phospholipase activity 200-fold." evidence="23">
<original>R</original>
<variation>K</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phospholipase or lysophosphatase activity." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phospholipase activity." evidence="20">
<original>C</original>
<variation>A</variation>
<location>
<position position="220"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes both phospholipase and lysophosphatase activities." evidence="20 22 23">
<original>S</original>
<variation>A</variation>
<variation>C</variation>
<variation>T</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phospholipase activity; when associated with A-331." evidence="20">
<original>C</original>
<variation>A</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phospholipase activity; when associated with A-324." evidence="20">
<original>C</original>
<variation>A</variation>
<location>
<position position="331"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases agonist-stimulated release of arachidonic acid." evidence="21">
<original>S</original>
<variation>A</variation>
<location>
<position position="505"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phospholipiase activity." evidence="23">
<original>D</original>
<variation>A</variation>
<location>
<position position="549"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces phospholipiase activity 2000-fold." evidence="23">
<original>D</original>
<variation>E</variation>
<location>
<position position="549"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces phospholipiase activity 300-fold." evidence="23">
<original>D</original>
<variation>N</variation>
<location>
<position position="549"/>
</location>
</feature>
<feature type="mutagenesis site" description="7-fold reduced phospholipase and lysophosphatase activities. 100-fold reduced phospholipase and lysophosphatase activities; when associated with A-195." evidence="20">
<original>S</original>
<variation>A</variation>
<location>
<position position="577"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phospholipase activity; when associated with A-634." evidence="20">
<original>C</original>
<variation>A</variation>
<location>
<position position="620"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phospholipase activity; when associated with A-620." evidence="20">
<original>C</original>
<variation>A</variation>
<location>
<position position="634"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phospholipase activity." evidence="20">
<original>C</original>
<variation>A</variation>
<location>
<position position="726"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="18"/>
<end position="29"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="34"/>
<end position="39"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="44"/>
<end position="49"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="51"/>
<end position="54"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="57"/>
<end position="60"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="70"/>
<end position="79"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="86"/>
<end position="93"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="96"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="100"/>
<end position="108"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="109"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="117"/>
<end position="124"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="125"/>
<end position="127"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="128"/>
<end position="137"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="143"/>
<end position="146"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="152"/>
<end position="177"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="179"/>
<end position="181"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="190"/>
<end position="194"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="198"/>
<end position="214"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="218"/>
<end position="220"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="221"/>
<end position="226"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="228"/>
<end position="239"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="241"/>
<end position="245"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="248"/>
<end position="260"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="263"/>
<end position="266"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="269"/>
<end position="284"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="291"/>
<end position="304"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="305"/>
<end position="307"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="313"/>
<end position="318"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="319"/>
<end position="321"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="326"/>
<end position="333"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="341"/>
<end position="343"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="344"/>
<end position="349"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="354"/>
<end position="356"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="357"/>
<end position="360"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="361"/>
<end position="363"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="365"/>
<end position="367"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="370"/>
<end position="373"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="376"/>
<end position="379"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="386"/>
<end position="393"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="396"/>
<end position="399"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="401"/>
<end position="404"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="417"/>
<end position="423"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="426"/>
<end position="429"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="463"/>
<end position="476"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="488"/>
<end position="490"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="492"/>
<end position="495"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="543"/>
<end position="548"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="550"/>
<end position="552"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="558"/>
<end position="561"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="564"/>
<end position="566"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="570"/>
<end position="575"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="588"/>
<end position="599"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="611"/>
<end position="615"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="619"/>
<end position="623"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="636"/>
<end position="641"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="646"/>
<end position="648"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="650"/>
<end position="652"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="660"/>
<end position="666"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="670"/>
<end position="672"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="687"/>
<end position="702"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="705"/>
<end position="718"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1BCI"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1CJY"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1RLW"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P50393"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00041"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00555"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10319815"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11416127"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18451993"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1869522"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1904318"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8083230"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8381049"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8619991"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8702602"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9430701"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9468497"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9665851"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="28" type="ECO:0000305"/>
<sequence length="749" mass="85239" checksum="EE71CA0EBE617856" modified="2011-01-11" version="2">
MSFIDPYQHIIVEHQYSHKFTVVVLRATKVTKGAFGDMLDTPDPYVELFISTTPDSRKRT
RHFNNDINPVWNETFEFILDPNQENVLEITLMDANYVMDETLGTATFTVSSMKVGEKKEV
PFIFNQVTEMVLEMSLEVCSCPDLRFSMALCDQEKTFRQQRKEHIRESMKKLLGPKNSEG
LHSARDVPVVAILGSGGGFRAMVGFSGVMKALYESGILDCATYVAGLSGSTWYMSTLYSH
PDFPEKGPEEINEELMKNVSHNPLLLLTPQKVKRYVESLWKKKSSGQPVTFTDIFGMLIG
ETLIHNRMNTTLSSLKEKVNTAQCPLPLFTCLHVKPDVSELMFADWVEFSPYEIGMAKYG
TFMAPDLFGSKFFMGTVVKKYEENPLHFLMGVWGSAFSILFNRVLGVSGSQSRGSTMEEE
LENITTKHIVSNDSSDSDDESHEPKGTENEDAGSDYQSDNQASWIHRMIMALVSDSALFN
TREGRAGKVHNFMLGLNLNTSYPLSPLSDFATQDSFDDDELDAAVADPDEFERIYEPLDV
KSKKIHVVDSGLTFNLPYPLILRPQRGVDLIISFDFSARPSDSSPPFKELLLAEKWAKMN
KLPFPKIDPYVFDREGLKECYVFKPKNPDMEKDCPTIIHFVLANINFRKYRAPGVPRETE
EEKEIADFDIFDDPESPFSTFNFQYPNQAFKRLHDLMHFNTLNNIDVIKEAMVESIEYRR
QNPSRCSVSLSNVEARRFFNKEFLSKPKA
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>